Cargando…

Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles

OBJECTIVES: We aimed to investigate potential associations between human leukocyte antigen (HLA) class I and class II alleles and the development of anaphylactic/anaphylactoid reactions in patients with multiple sclerosis (MS) treated with natalizumab. METHODS: HLA class I and II genotyping was perf...

Descripción completa

Detalles Bibliográficos
Autores principales:	de la Hera, Belén, Urcelay, Elena, Brassat, David, Chan, Andrew, Vidal-Jordana, Angela, Salmen, Anke, Villar, Luisa Maria, Álvarez-Cermeño, José Carlos, Izquierdo, Guillermo, Fernández, Oscar, Oliver, Begoña, Saiz, Albert, Ara, Jose Ramón, Vigo, Ana G., Arroyo, Rafael, Meca, Virginia, Malhotra, Sunny, Fissolo, Nicolás, Horga, Alejandro, Montalban, Xavier, Comabella, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268037/ https://www.ncbi.nlm.nih.gov/pubmed/25520955 http://dx.doi.org/10.1212/NXI.0000000000000047

Ejemplares similares

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
por: Malhotra, Sunny, et al.
Publicado: (2018)

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015)

Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis
por: Ortiz, Miguel A., et al.
Publicado: (2015)

Anaphylactoid Edema
por: Levine, Robert J.
Publicado: (1969)

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course
por: Gil-Varea, Elia, et al.
Publicado: (2018)

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study
por: Fernández, O., et al.
Publicado: (2012)

Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
por: Tur, Carmen, et al.
Publicado: (2013)

Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab
por: Dominguez-Mozo, Maria Inmaculada, et al.
Publicado: (2020)

Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
por: Hoepner, Robert, et al.
Publicado: (2014)

Metabolomic signatures associated with disease severity in multiple sclerosis
por: Villoslada, Pablo, et al.
Publicado: (2017)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
por: Toboso, Inmaculada, et al.
Publicado: (2020)

The Anaphylactoid Syndrome of Pregnancy: Two Autopsy Cases
por: Plantzas, Ioannis, et al.
Publicado: (2023)

Immunomodulatory Effects Associated with Cladribine Treatment
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis
por: Cantó, Ester, et al.
Publicado: (2014)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Anaphylactoid to polyurethane foam (yellow foam) among architects
por: Wiwanitkit, Viroj
Publicado: (2009)

Untoward (Anaphylactoid) Reaction in I. V. Iron Therapy
por: Kane, B. G.
Publicado: (1953)

5-HMF induces anaphylactoid reactions in vivo and in vitro
por: Li, Encan, et al.
Publicado: (2020)

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
por: Bustamante, Marta F., et al.
Publicado: (2015)

Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
por: Schwab, Nicholas, et al.
Publicado: (2016)

Macromolecules in polysorbate 80 for injection: an important cause of anaphylactoid reactions
por: Li, Yue, et al.
Publicado: (2022)

Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β
por: Muñoz, Úrsula, et al.
Publicado: (2022)

Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses
por: Serra López-Matencio, Jose M., et al.
Publicado: (2021)

A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
por: Gil-Varea, Elia, et al.
Publicado: (2020)

TISSUE REACTIONS TO ANAPHYLACTIC AND ANAPHYLACTOID STIMULI; PROTEOLYSIS AND RELEASE OF HISTAMINE AND HEPARIN
por: Ungar, Georges, et al.
Publicado: (1955)

A Reliable Method for the Evaluation of the Anaphylactoid Reaction Caused by Injectable Drugs
por: Wang, Fang, et al.
Publicado: (2016)

Effects of NO/cGMP inhibitors in a rat model of anaphylactoid shock
por: Albuquerque, A.A.S., et al.
Publicado: (2020)

Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023)

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
por: Link, Jenny, et al.
Publicado: (2017)

Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
por: Aguirre, Clara, et al.
Publicado: (2020)

Treatment with MOG-DNA vaccines induces CD4(+)CD25(+)FoxP3(+) regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis
por: Fissolo, Nicolás, et al.
Publicado: (2012)

Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2011)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

The prevention of anaphylactoid reactions to iodinated radiological contrast media: a systematic review
por: Delaney, Anthony, et al.
Publicado: (2006)

ACTIVATION OF PROFIBRINOLYSIN BY ANTIGEN-ANTIBODY REACTION AND BY ANAPHYLACTOID AGENTS; ITS RELATION TO COMPLEMENT
por: Ungar, Georges, et al.
Publicado: (1953)

A case of anaphylactoid purpura nephritis accompanied by pulmonary hemorrhage and review of the literature
por: REN, XIANQING, et al.
Publicado: (2013)

The Severe Adverse Reaction to Vitamin K(1) Injection Is Anaphylactoid Reaction but Not Anaphylaxis
por: Mi, Yan-Ni, et al.
Publicado: (2014)

Delayed severe anaphylactoid reaction following retrograde pyelogram: A case report
por: Pooli, Aydin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qq5d442v4nfvjedp33qovh7nd6